TFF Group 

$17.50
39
-$0.50-2.78% Wednesday 15:58

Statistics

Day High
20.14
Day Low
20.14
52W High
42.75
52W Low
17.5
Volume
100
Avg. Volume
27
Mkt Cap
379.4M
P/E Ratio
14.23
Dividend Yield
3.27%
Dividend
0.57

Upcoming

Dividends

3.27%Dividend Yield
Nov 25
$0.57
Nov 24
$0.65
Nov 23
$0.64
Nov 22
$0.40
Nov 21
$0.40
10Y Growth
12.79%
5Y Growth
7.39%
3Y Growth
-5.9%
1Y Growth
N/A

Earnings

7JanExpected
Q2 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

7.17%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
471.24MRevenue
33.78MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FRFTF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap319.99B
Merck & Co., Inc. is a global healthcare company that develops respiratory drugs, competing directly with TFF Pharmaceuticals' focus on developing and commercializing drug products based on its patented Thin Film Freezing technology for respiratory diseases.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline plc is a multinational pharmaceutical company that produces a wide range of prescription medicines, vaccines, and consumer healthcare products, including treatments for respiratory conditions, making it a competitor to TFF Pharmaceuticals.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines in several therapeutic areas, including respiratory, making it a competitor to TFF.
Pfizer
PFE
Mkt Cap138.61B
Pfizer Inc. is a global pharmaceutical corporation that develops and manufactures drugs and vaccines for a wide range of medical disciplines, including respiratory diseases, competing with TFF Pharmaceuticals' product offerings.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.34B
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that specializes in generic and specialty medicines, including treatments for respiratory conditions, making it a direct competitor to TFF Pharmaceuticals.
Novartis
NVS
Mkt Cap305.1B
Novartis AG is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including respiratory drugs, competing with TFF Pharmaceuticals in the respiratory treatment market.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, including for respiratory diseases, making it a competitor to TFF Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
Bristol-Myers Squibb Company is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, including respiratory conditions, competing with TFF.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.59B
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, and commercializes medicines for the treatment of serious medical conditions, including respiratory diseases, making it a competitor to TFF Pharmaceuticals.
Sanofi
SNY
Mkt Cap103.32B
Sanofi is a global healthcare leader that researches, develops, and distributes therapeutic solutions focused on patients' needs, including respiratory treatments, making it a competitor to TFF Pharmaceuticals.

About

TFF Group, together with its subsidiaries, engages in the wine and spirits ageing in the United States, Europe, France, Asia, and internationally. It is involved in the forestry business, wine cooperage, stave milling, whisky and bourbon cooperage, cask making, and stainless-steel vat making. The company also offers wood products for oenology. It serves the wine, bourbon, and whisky markets. The company was formerly known as Tonnellerie François Frères. TFF Group was founded in 1910 and is based in Saint-Romain-en-Viennois, France.
Show more...
CEO
Mr. Jerome Francois
Employees
1575
Country
France
ISIN
FR0013295789

Listings

0 Comments

Share your thoughts

FAQ

What is TFF Group stock price today?
The current price of FRFTF is $17.50 USD — it has decreased by -2.78% in the past 24 hours. Watch TFF Group stock price performance more closely on the chart.
What is TFF Group stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange TFF Group stocks are traded under the ticker FRFTF.
What is TFF Group market cap?
Today TFF Group has the market capitalization of 379.4M
What is TFF Group revenue for the last year?
TFF Group revenue for the last year amounts to 471.24M USD.
What is TFF Group net income for the last year?
FRFTF net income for the last year is 33.78M USD.
Does TFF Group pay dividends?
Yes, FRFTF dividends are paid annual. The last dividend per share was 0.57 USD. As of today, Dividend Yield (FWD)% is 3.27%.
How many employees does TFF Group have?
As of July 10, 2026, the company has 1,575 employees.
In which sector is TFF Group located?
TFF Group operates in the Materials sector.
When did TFF Group complete a stock split?
TFF Group has not had any recent stock splits.
Where is TFF Group headquartered?
TFF Group is headquartered in Saint-Romain-en-Viennois, France.